Advances in targeting the folate receptor in the treatment/imaging of cancers

Marcos Fernández1, Faiza Javaid1, Vijay Chudasama1,2

  • 1Department of Chemistry , University College London , London , UK.

Chemical Science
|April 21, 2018
PubMed

Insights

Folate receptor (FR) targeted therapies offer new ways to image and treat cancers. Various approaches, including drug conjugates and nanotechnology, exploit FR overexpression on tumor cells for targeted delivery.

Area of Science:

  • Oncology
  • Biochemistry
  • Nanotechnology

Background:

  • The folate receptor (FR) is overexpressed on many tumor cells, making it a valuable biomarker.
  • Targeting FR allows for specific delivery and imaging of cancer cells.

Purpose of the Study:

  • To review diverse strategies for exploiting the folate receptor for cancer diagnostics and therapeutics.
  • To highlight the potential of FR-targeted technologies in revolutionizing cancer treatment.

Main Methods:

  • Development of folate-conjugated small molecule-drug conjugates (SMDCs).
  • Utilizing FR-targeting antibodies, both alone and as antibody-drug conjugates.
  • Employing nanotechnology-folate platforms for targeted delivery and imaging.
  • Creating imaging variants of FR-targeted agents.

Main Results:

  • Multiple FR-targeted technologies have been developed, including SMDCs, antibody-based therapies, and nanomedicines.
  • These approaches enable targeted drug delivery and imaging of cancer cells.
  • The combination of small molecule, nanoparticle, and protein-based targeting provides comprehensive knowledge.

Conclusions:

  • Exploiting the folate receptor holds significant potential to revolutionize cancer therapy and imaging.
  • FR-targeted technologies offer promising avenues for developing sophisticated drug conjugates.
  • The diverse technological approaches targeting FR provide broad insights for future cancer treatments.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
484
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
524
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups


Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.2K